A Shot to End AIDS: Global Access Disparities

This AP News article discusses a new, highly effective twice-yearly HIV prevention shot, lenacapavir (Sunlenca). While the drugmaker, Gilead, will provide generic versions to 120 low-income countries, it has excluded several Latin American nations with rising HIV rates, raising concerns about equitable access. The article highlights the drug's potential to significantly reduce HIV infections, especially among marginalized communities, but emphasizes the critical need for broader global distribution to maximize its impact. Experts and advocacy groups are calling for increased access, suggesting mechanisms like compulsory licenses to overcome barriers. The article also notes that other prevention methods exist but are not always as effective or accessible.
--------------------------------------------
Source Credit: https://apnews.com/article/hiv-infections-aids-prevention-shot-02606f7d7892f0baf55bd0a0ff2ba3de
-----------------------------------------------
https://www.buymeacoffee.com/otiswho
https://rumble.com/user/OtisWho
Anchor: https://anchor.fm/otiswho
Podbean: https://OtisWho.Podbean.com
https://www.tiktok.com/@otiswhopodcast
Facebook: OtisWho? Podcast
Instagram: @OtisWho1
Otiswho1@gmail.com
-----------------------------------------------
Theme Song Produced by: OtisWho? Music